JKHY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Jack Henry & Associates Inc (JKHY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, increased dividend payouts, and favorable long-term growth prospects make it a solid investment option. Despite short-term technical weakness, the stock's oversold RSI and historical safe-haven status provide a compelling entry point.
The stock is currently oversold with an RSI of 17.836, indicating potential for a rebound. MACD is negatively expanding (-2.099), suggesting short-term bearish momentum. Key support is at $158.477, with the current pre-market price of $157.69 slightly below this level. Moving averages are converging, signaling potential stabilization. Overall, the technical indicators suggest a short-term weakness but an opportunity for long-term investors to buy at a discounted price.
["Strong Q2 financial performance with revenue up 7.93% YoY, net income up 27.41% YoY, and EPS up 28.36% YoY.", "Dividend increase to $0.61 per share, continuing a 22-year trend of dividend growth.", "Positive analyst upgrades with price targets raised to as high as $220, citing share gains, improved market positioning, and favorable valuation.", "Partnership with Blue Sky Bank, showcasing the company's ability to attract high-value clients and drive growth."]
["Insider selling has increased significantly (9482.56% over the last month), which could indicate caution among company executives.", "Short-term technical weakness with MACD and support levels breached.", "Options sentiment shows a higher put-call ratio, indicating bearish sentiment in the near term."]
In Q2 2026, Jack Henry reported revenue of $619.33M (+7.93% YoY), net income of $124.67M (+27.41% YoY), and EPS of $1.72 (+28.36% YoY). Gross margin improved to 43.33% (+3.17% YoY), reflecting strong profitability and operational efficiency.
Analysts are increasingly bullish on the stock, with multiple upgrades to Outperform and price targets raised to as high as $220. Analysts cite strong revenue growth, share gains, and a discounted valuation as key drivers for their optimism.
